ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

May 6, 1983

Weight Gain After Diagnosis Increases Risk Of Death

December 28, 2007

Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center

March 2, 2012

Curt, Ozols, Brown Leaving NCI; More DCT Staff Changes

June 10, 1988

DO RFAs cut Into R01 Grant Pool? Board Asks

July 2, 1999